about
Treatment of higher risk myelodysplastic syndrome patients unresponsive to hypomethylating agents with ON 01910.NaContribution of classical end-joining to PTEN inactivation in p53-mediated glioblastoma formation and drug-resistant survival.Akt3 is responsible for the survival and proliferation of embryonic stem cellsIdentification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics dataInhibition of heat-induced apoptosis in rat small intestine and IEC-6 cells through the AKT signaling pathway.The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.Astrocyte elevated gene-1 interacts with Akt isoform 2 to control glioma growth, survival, and pathogenesis.High β-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression.Targeting class IA PI3K isoforms selectively impairs cell growth, survival, and migration in glioblastoma.Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression.Akt inhibitors in clinical development for the treatment of cancer.Akt2 knock-down reveals its contribution to human lung cancer cell proliferation, growth, motility, invasion and endothelial cell tube formationThe allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures.MiR-422a acts as a tumor suppressor in glioblastoma by targeting PIK3CA.Driver or passenger effects of augmented c-Myc and Cdc20 in gliomagenesis.Role of Akt in human malignant glioma: from oncogenesis to tumor aggressiveness.The role of AKT isoforms in glioblastoma: AKT3 delays tumor progression.Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.Knockdown of the AKT3 (PKBγ), PI3KCA, and VEGFR2 genes by RNA interference suppresses glioblastoma multiforme T98G cells invasiveness in vitro.Knockdown of AKT3 (PKBγ) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells.In vitro 3D colon tumor penetrability of SRJ09, a new anti-cancer andrographolide analog.Protective role of dietary-supplemented selenium and vitamin E in heat-induced apoptosis and oxidative stress in mice testes.IGF signaling pathway analysis of osteosarcomas reveals the prognostic value of pAKT localization.Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids.Inhibition of HSP27 alone or in combination with pAKT inhibition as therapeutic approaches to target SPARC-induced glioma cell survival.Growth inhibition of malignant glioblastoma by DING protein.Nonredundant functions for Akt isoforms in astrocyte growth and gliomagenesis in an orthotopic transplantation model.AEG-1-AKT2: A novel complex controlling the aggressiveness of glioblastoma.OverAKT3: tumor progression and chemoresistance.MicroRNA-target cross-talks: Key players in glioblastoma multiforme.Cytotoxic Effects of Environmental Toxins on Human Glial Cells.Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.Triangle of AKT2, miRNA, and Tumorigenesis in Different Cancers.Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models.Role of Akt Isoforms Controlling Cancer Stem Cell Survival, Phenotype and Self-Renewal.MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3.[Current status of Akt in non-small cell lung cancer].
P2860
Q24597616-9D7B753A-D3DE-4892-AFA7-AE0D8693BF9FQ30363869-9DB7DE96-6324-4E7A-87E4-BB6C07593119Q30491624-09C878CF-6DE5-45CD-9B0E-B9169AFA07B9Q30956148-7A792BAC-585B-4E12-ABAB-843E87734EA3Q34455692-4A0E499F-1E5B-4648-A9FE-9EF173DA20A3Q34468816-064C2427-4899-45AB-B621-7FF2ACCC483EQ34718047-7EB0D7C0-C153-4083-BA52-CFDC9AE19E6EQ35021344-EEC375EB-0D46-4029-91E5-B819EDA868A7Q35143738-722D5A57-0B64-4BE1-A3A5-2D83E2BB6B0EQ35212521-9AB7EE4A-DB12-4F31-B7CE-3D6F1A3FB9F2Q35628576-D1D1DD09-F90F-42B3-A2B4-DA3CB4984F22Q35909804-13661B7C-984F-4E01-B639-E20192B156C5Q36315289-148208FD-E9B7-49B7-BBF7-100AD3339A57Q37215533-2AC4F84A-15F8-48B9-8853-F12D891966C7Q37269061-15F60E14-3B6E-4E05-9386-0DAB85E929A2Q38183283-2658CF07-9FDE-4F17-B912-5355DC484C89Q38740114-A274072B-F24F-424D-B7CD-DCAFC4591DBAQ38791893-119AD9F5-A233-4583-A68B-935C634DD192Q38929199-12FE6DC1-B480-4061-A3DA-F633D4046174Q38981090-0C7A18EA-C6CF-4241-B0F3-815A995421F1Q38990370-EF4E986C-9944-4ACE-8BCD-6E586638D50EQ39072850-A68271EB-5628-4971-A4A2-F56C131E2A24Q39326887-A73A3E59-0A30-48B5-B22F-9687198E9808Q39365958-9382923F-D1FC-4B17-B042-0630BDCEE784Q39368816-6FFD3668-931C-4C9C-8F60-3AF9E5C8C64CQ39448314-E7EEC72D-4D5D-4EFB-A128-5195543A124FQ39555624-75EC5885-132B-49E2-81F9-C6010C420519Q42096175-915021CD-05CD-46EC-A84F-B4842BDEB3DCQ43207315-676B62E8-454F-4279-A40A-82A20623331CQ46190130-2BE81413-3401-490F-BD85-9A8AED7C394DQ46467372-49615632-E51F-4E2F-BE12-409F74A11FD4Q48622244-6C280AD1-181B-4016-BC38-DBD15001F449Q49333350-3B0EA05F-2366-4581-92CC-DDDABA103D63Q50736424-03EE1801-5432-41F5-BA45-8D995D9E3BF9Q52666361-9C44418B-9DDE-4981-BE1C-769663EA8E68Q53093295-081D39F1-DECA-4AFD-B036-EA623F0FDA26Q55443268-068E821E-2154-43BA-A86A-429F9BFC874A
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@en
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@nl
type
label
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@en
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@nl
prefLabel
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@en
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@nl
P2093
P2860
P356
P1433
P1476
Akt2 and Akt3 play a pivotal role in malignant gliomas.
@en
P2093
Hideo Mure
Kazuhito Matsuzaki
Kazuyuki Kuwayama
Keiko T Kitazato
Shinji Nagahiro
Teruyoshi Kageji
Yoshifumi Mizobuchi
P2860
P304
P356
10.1093/NEUONC/NOP026
P577
2009-12-21T00:00:00Z